Business Description
Shoulder Innovations Inc
NAICS : 339112
SIC : 3841
ISIN : US82537J1088
Total Employee Number:
75Description
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System. Geographically, the company operates in United States and are planning to expand.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 7.23 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-Equity | 0.11 | |||||
Debt-to-EBITDA | -0.36 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 8.74 | |||||
Beneish M-Score | -2.04 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 27.4 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 30.34 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 34.69 | |||||
9-Day RSI | 45.68 | |||||
14-Day RSI | 51.09 | |||||
3-1 Month Momentum % | 29.8 | |||||
6-1 Month Momentum % | 17.92 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 11.81 | |||||
Quick Ratio | 10.04 | |||||
Cash Ratio | 8.8 | |||||
Days Inventory | 543.07 | |||||
Days Sales Outstanding | 53.31 | |||||
Days Payable | 188.48 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -0.05 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 76.81 | |||||
Operating Margin % | -57.48 | |||||
Net Margin % | -81.78 | |||||
EBITDA Margin % | -76.63 | |||||
FCF Margin % | -81.26 | |||||
OCF Margin % | -64 | |||||
ROE % | -77.58 | |||||
ROA % | -34.25 | |||||
ROIC % | -102.8 | |||||
ROC (Joel Greenblatt) % | -155.66 | |||||
ROCE % | -38.61 | |||||
Moat Score | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 6.89 | |||||
PB Ratio | 3.13 | |||||
Price-to-Tangible-Book | 3.13 | |||||
EV-to-EBIT | -7.19 | |||||
EV-to-EBITDA | -7.83 | |||||
EV-to-Revenue | 6 | |||||
EV-to-FCF | -7.38 | |||||
| Price-to-Net-Current-Asset-Value | 3.51 | |||||
| Price-to-Net-Cash | 5.13 | |||||
Earnings Yield (Greenblatt) % | -13.91 | |||||
FCF Yield % | -10.51 |
GF Valueâ„¢
Shoulder Innovations Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shoulder Innovations Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-11 16:30 | In 112 days | ||
| Third quarter earnings results for 2026 | 2026-11-11 | In 111 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-06 16:30 | In 15 days | ||
| Second quarter earnings results for 2026 | 2026-08-06 | In 14 days | ||
| General meeting for 2026 | 2026-06-26 15:00 | 21.61 (+9.70%) | ||
| Goldman Sachs 47th Annual Global Healthcare Conference | 2026-06-09 | 14.15 (-0.98%) | ||
| First quarter earnings conference call for 2026 | 2026-05-13 16:30 | 13.37 (+0.91%) | ||
| First quarter earnings results for 2026 | 2026-05-13 | 13.37 (+0.91%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-10 16:30 | 13.39 (+2.92%) | ||
| Annual report for 2025 | 2026-03-10 | 13.39 (+2.92%) |
Show
Entries
Guru Commentaries on NYSE:SI
No articles.
Press Release
Articles on Shoulder Innovations Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers